|
Scientist, Hybridoma Technology
From:
Company: Elan Pharmaceuticals (see all of this employer's jobs)
Phone: 6508777647
Fax: 1234567890
 Apply by eMail:do_not_reply@invalidemail.com
|
Job Reference ID:
5050502
Category:
Scientific
Duration:
Fulltime, Permanent
City, ST:
South San Francisco, California
Country:
United States |
|
Description:
SCIENTIST, HYBRIDOMA TECHNOLOGY
Primary objective of position:
Generate, characterize and develop novel monoclonal antibodies and support their development as therapeutics.
The successful candidate will be an expert in hybridoma technologies, scientifically curious and highly adaptable to new technologies and methods. The position requires a person with intellectual flexibility with adapting and automating methods and needs a problem solving mentality to tackle multiple targets, each with unique challenges. This person will also need to either supervise or work closely and train more junior personnel.
Major Duties/Responsibiltites:
60% generation/characterization of novel monoclonal antibodies and hybridomas
20% Characterization of humanized development candidates, tertiary screening of antibody properties
10% Report writing/editing, data presentation
10% Support of in vivo efficacy testing in a variety of disease models
Job Qualifications
Experience/Education: PhD. 5 years hybridoma/antibody related experience
Special Training: Hybridoma generation and characterization. Antibody related assays including ELISA, Western-blot, kinetic binding analysis with label-free antibody technologies (eg., BIAcore or Forte Bio). Familiarity with Clonepix is a plus.
Skills/Abilities: Must be able to immunize and titer mice and rats, perform hybridoma fusions and cloning. Supervisory experience. Rapidly adapt to new technologies and automation of workflows. Excellent written and oral communication skills. Antibody purification experience. Protein purification skills desirable.
Apply by eMail:do_not_reply@invalidemail.com
Job Created:
Thu Oct 08 2009 06:06:55 AM
Last Modified: Fri Nov 20 2009 06:24:44 AM
|
